Septic Arthritis and Multifocal Osteomyelitis Caused by Capnocytophaga Canimorsus: A Case Report

Capnocytophaga; Osteomyelitis; Septic arthritisCapnocitofaga; Osteomielitis; Artritis sépticaCapnocytophaga; Osteomielitis; Artritis sèpticaMicrobiological diagnosis of chronic osteoarticular infections remains a major challenge, particularly when the clinical presentation is atypical and the pathogen is uncommon. In this unique case, Capnocytophaga canimorsus, a microorganism belonging to the oral microbiota of some domestic animals, caused septic arthritis and multifocal osteomyelitis in the long bone of a 43-year-old immunocompetent man. The patient was treated with two-stage surgery and local and systemic antibiotic therapy, and had a successful recovery. C. canimorsus should be considered as a possible etiological agent in patients with osteoarticular pathology and a history of exposure to domestic animals

Role of asymptomatic bacteriuria on early periprosthetic joint infection after hip hemiarthroplasty. BARIFER randomized clinical trial

[Purpose] To evaluate preoperative asymptomatic bacteriuria (ASB) treatment to reduce early-periprosthetic joint infections (early-PJIs) after hip hemiarthroplasty (HHA) for fracture.[Methods] Open-label, multicenter RCT comparing fosfomycin-trometamol versus no intervention with a parallel follow-up cohort without ASB. Primary outcome: early-PJI after HHA.[Results] Five hundred ninety-four patients enrolled (mean age 84.3); 152(25%) with ASB (77 treated with fosfomycin-trometamol/75 controls) and 442(75%) without. Despite the study closed without the intended sample size, ASB was not predictive of early-PJI (OR: 1.06 [95%CI: 0.33–3.38]), and its treatment did not modify early-PJI incidence (OR: 1.03 [95%CI: 0.15–7.10]). [Conclusions] Neither preoperative ASB nor its treatment appears to be risk factors of early-PJI after HHA. ClinicalTrials.gov Identifier: Eudra CT 2016-001108-47.This work was supported by the Spanish Clinical Research Network (SCReN), co-finaced by the ISCIII-Subdirección General de Evaluación y Fomento de la Investigación, through the project PI15/02161 and by the Plan Nacional de I+D+i 2013-016 and ISCIIII, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0003)-co-financed by European Development Regional Fund “A way to achieve Europe,” Operative program Intelligent Growth 2014-2020.Peer reviewe

Guia per a la prevenció i el control de les toxiinfeccions alimentàries

Toxiinfecció alimentària; Medicina preventiva; Seguretat dels alimentsFood poisoning; Preventive medicine; Food safetyToxiinfección alimentaria; Medicina preventiva; Seguridad de los alimentosEn aquesta segona edició de la Guia per a la prevenció i el control de les toxiinfeccions alimentàries es presenta l’etiologia, la patogènia, el tractament i, fonamentalment, la profilaxi de les toxiinfeccions alimentàries més importants i freqüents al nostre medi. Tracta de les normes de declaració, recollida de mostres i mesures de prevenció, i informa sobre les normes de conservació i les mesures de preparació dels aliments per tal d’evitar aquestes malalties

Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance

Objectives: Our aim was to analyze the prevalence of multidrug-resistant bacterial infections in lung transplant donors and to evaluate its influence on donor-derived bacterial infections.Methods: We conducted a retrospective study of adult patients who underwent lung transplantation (2013-2016) at our hospital. Donor-derived bacterial infection was defined as the isolation of the same bacteria with identical antibiotic susceptibility patterns in the recipient and the perioperative cultures from the donor during the first month posttransplantation. We utilized a preventive antibiotic strategy adapted to the bacteria identified in donor cultures using systemic and nebulized antibiotics.Results: 252 lung transplant recipients and 243 donors were included. In 138/243 (56.8%) donors, one bacterial species was isolated from at least one sample; graft colonization (118/243; 48.6%), blood cultures (5/243; 2.1%) and the contamination of preservation fluids (56/243; 23%). Multidrug-resistant bacteria were isolated from 12/243 (4.9%) donors; four Enterobacterales, four Stenotrophomonas maltophilia, three Pseudomonas aeruginosa and one methicillin-resistant Staphylococcus aureus. There was no transmission of these multidrug-resistant bacteria. Donor-derived infections, primarily tracheobronchitis due to non-MDR bacteria, were diagnosed in 7/253 (2.9%) recipients, with good clinical outcomes.Conclusions: The lungs of donors colonized with multidrug-resistant bacteria may be safely used when recipients receive prompt tailored antibiotic treatment. (C) 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved

Guia per a la prevenció i el control de les toxiinfeccions alimentàries

Toxiinfecció alimentària; Medicina preventiva; Seguretat dels alimentsFood poisoning; Preventive medicine; Food safetyToxiinfección alimentaria; Medicina preventiva; Seguridad de los alimentosEn aquesta segona edició de la Guia per a la prevenció i el control de les toxiinfeccions alimentàries es presenta l’etiologia, la patogènia, el tractament i, fonamentalment, la profilaxi de les toxiinfeccions alimentàries més importants i freqüents al nostre medi. Tracta de les normes de declaració, recollida de mostres i mesures de prevenció, i informa sobre les normes de conservació i les mesures de preparació dels aliments per tal d’evitar aquestes malalties